Bal Pharma Ltd (BALPHARMA) Stock Price & News

BALPHARMA:NSE

Bal Pharma Ltd

₹98.97

+1.29%

(+1.26) 1D

Oct 13, 12:43:32 PM GMT+5:30 · INR

All symbols

	Symbol	Price	Change	% Change

Generating top insights for BALPHARMA...

Open

₹101.20

High

₹101.20

Low

₹95.10

Mkt. cap

1.58B

Avg. vol.

111.11K

Volume

7.43K

Dividend

1.21%

Quarterly dividend

₹0.30

Ex-dividend date

Sep 17, 2026

P/E ratio

21.81

52-wk high

₹124.60

52-wk low

₹60.00

EPS

₹4.54

Shares outstanding

14.17M

No. of employees

939

Open

₹101.20

High

₹101.20

Low

₹95.10

Mkt. cap

1.58B

Avg. vol.

111.11K

Volume

7.43K

Dividend

1.21%

Quarterly dividend

₹0.30

Ex-dividend date

Sep 17, 2026

P/E ratio

21.81

52-wk high

₹124.60

52-wk low

₹60.00

EPS

₹4.54

Shares outstanding

14.17M

No. of employees

939

Related stocks

CENTUM

Centum Electronics Ltd

₹3,995.70

-1.56%

AXISCADES

Axiscades Technologies Ltd

₹2,009.40

-1.17%

BOSCH-HCIL

Bosch Home Comfort India Ltd

News stories

From web sources and news partners

ACCESS Newswire

1 hour ago

Abishai Financial Asia Reports S&P 500 Tech-Led Advance

TradingView

1 hour ago

Stock Market: Will S&P 500 Open Up or Down Today?

The Motley Fool

11 minutes ago

If You Invest $5,000 in VOO Today, Here's What History Says It Could Be Worth in 20 Years

BBN Times

9 hours ago

Dow Jones (DJIA) Rises to 51,850.31 as Energy and Software Gains Offset a Chip Sell-Off

About Bal Pharma Ltd

CEO-

Employees939

Founded1987

Headquarters-

SectorPharmaceutical industry

Websitebalpharma.com

All values in INR	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	740.25M	876.90M	840.76M	886.16M
Cost of goods sold	399.35M	461.60M	436.91M	511.52M
Cost of revenue	399.35M	461.60M	436.91M	511.52M
Research and development expenses	-	-	-	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	162.71M	173.24M	189.03M	170.64M
Operating expense	306.30M	352.15M	346.41M	322.99M
Total operating expenses	705.66M	813.74M	783.32M	834.51M
Operating income	34.59M	63.15M	57.43M	51.66M
Other non operating income	11.16M	3.26M	-37.86M	4.38M
EBT including unusual items	7.17M	17.91M	32.18M	11.38M
EBT excluding unusual items	7.17M	17.91M	31.04M	11.38M
Income tax expense	-	-	-3.86M	-
Effective tax rate	-	-	-12.00%	-
Other operating expenses	120.88M	146.61M	126.80M	124.52M
Net income	7.10M	17.80M	35.94M	11.24M
Net profit margin	0.96%	2.03%	4.27%	1.27%
Earnings per share	-	-	-	-
Interest and investment income	-	-	9.53M	-
Interest expense	-38.58M	-48.51M	-21.20M	-44.66M
Net interest expenses	-38.58M	-48.51M	-11.67M	-44.66M
Depreciation and amortization charges	22.71M	32.30M	30.58M	27.82M
EBITDA	58.55M	77.54M	72.77M	79.35M
Gain or loss from assets sale	-	-	-	-

Finance

Ask anything